Product Information
OXCARBAZEPINE 300 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1637 per EA under NDC 72603027101. Its NADAC has been published 86 times since Jan 1, 2025.
FDA first approved this application on Jan 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603027101
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA215939FDA Approved
1/11/2022
TE Code
AB
On Market Since
9/1/2024
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE 300 MG TABLET has been published 86 times since Jan 1, 2025, and over the history we have for it it has declined 2.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1637 per EA |
|---|---|
| All-time high | $0.1873 (Apr 16, 2025) |
| All-time low | $0.1635 (Jul 22, 2026) |
| 52-week high | $0.1747 |
| 52-week low | $0.1635 |
| Median price | $0.1728 |
| Average price | $0.1729 |
| Largest weekly change | +7.1% (Feb 19, 2025) |
| Weeks tracked | 86 |
| Tracking since | Jan 1, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 300 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1637 per EA (NDC 72603027101), effective Aug 19, 2026.
How has the price of OXCARBAZEPINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE 300 MG TABLET has declined 2.4%. It has been tracked across 86 weekly CMS publications since Jan 1, 2025.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 300 MG TABLET?
Since Jan 1, 2025, the NADAC for OXCARBAZEPINE 300 MG TABLET has ranged from a low of $0.1635 (Jul 22, 2026) to a high of $0.1873 (Apr 16, 2025), with a median of $0.1728 per EA.
Are there cheaper alternatives to OXCARBAZEPINE 300 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OXCARBAZEPINE 300 MG TABLET?
OXCARBAZEPINE 300 MG TABLET (NDC 72603027101) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.